We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current HNSPF market cap is 11.15B. The company's latest EPS is CNY 0.5524 and P/E is 3.40.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 8.68B | 8.69B | 9.94B | 9.38B | 10.1B |
| Operating Income | 2.83B | 2.83B | 3.04B | 2.78B | 2.84B |
| Net Income | 2.56B | 2.57B | 2.71B | 2.58B | 3.28B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 19.58B | 20.79B | 27.16B | 30B | 33.04B |
| Total Liabilities | 6.53B | 2.92B | 7.13B | 7.35B | 7.24B |
| Total Equity | 13.04B | 17.88B | 20.03B | 22.65B | 25.79B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | 3.33B | 2.39B | 2.58B | 2.74B | 3.12B |
| Investing | -7.08B | -2.87B | -2.26B | -5.94B | 1.07B |
| Financing | 7.99B | -1.04B | 3.42B | -818.14M | -753.7M |
| Market Cap | 11.15B |
| Price to Earnings Ratio | 3.40 |
| Price to Sales Ratio | 1.1 |
| Price to Cash Ratio | 0.5 |
| Price to Book Ratio | 0.43 |
| Dividend Yield | - |
| Shares Outstanding | 5.93B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 25.33% |
| 52 Week High | 1.88 |
| 52 Week Low | 1.50 |
| Spread (Intraday) | 6.14 (86.65%) |
| Company Name | Hansoh Pharmaceutical Group Co Ltd (PK) |
| Address |
p.o. box 309 grand cayman KY1-1104 |
| Website | https://www.hspharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
